Uss Investment Management LTD Vertex Pharmaceuticals Inc Transaction History

Uss Investment Management LTD

$15.4 Billion
Q2 2025

A detailed history of Uss Investment Management LTD transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Uss Investment Management LTD holds 44,154 shares of VRTX stock, worth $18.8 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

44,154

Previous 44,391 0.53%

Holding current value

$18.8 Million

Previous $21.5 Million 8.66%

% of portfolio

0.13%

Previous 0.17%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$421.16 - $509.5 $99,814 - $120,751	-237 Reduced 0.53%	44,154 $19.7 Million
Q1 2025 May 14, 2025	SELL	$402.49 - $513.76 $4,829 - $6,165	-12 Reduced 0.03%	44,391 $21.5 Million
Q4 2024 Feb 13, 2025	SELL	$396.64 - $516.74 $1.19 Million - $1.55 Million	-2,996 Reduced 6.32%	44,403 $17.9 Million
Q3 2024 Nov 13, 2024	SELL	$460.0 - $505.78 $458,620 - $504,262	-997 Reduced 2.06%	47,399 $22 Million
Q2 2024 Aug 13, 2024	BUY	$392.81 - $485.53 $384,168 - $474,848	978 Added 2.06%	48,396 $22.7 Million
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $590,742 - $646,369	1,449 Added 3.15%	47,418 $19.8 Million
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $2.27 Million - $2.72 Million	-6,620 Reduced 12.59%	45,969 $18.7 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $367,601 - $393,994	1,087 Added 2.11%	52,589 $18.3 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $177,018 - $198,125	563 Added 1.11%	51,502 $18.1 Million
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $743,478 - $848,137	2,625 Added 5.43%	50,939 $16 Million
Q3 2022 Nov 08, 2022	SELL	$273.83 - $305.53 $5.15 Million - $5.75 Million	-18,809 Reduced 28.02%	48,314 $14 Million
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $751,167 - $935,282	-3,197 Reduced 4.55%	67,123 $18.9 Million
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $1.31 Million - $1.54 Million	5,908 Added 9.17%	70,320 $18.4 Million
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $7.51 Million - $8.4 Million	41,375 Added 179.6%	64,412 $11.7 Million
Q3 2020 Oct 30, 2020	BUY	$255.65 - $303.1 $225,994 - $267,940	884 Added 3.99%	23,037 $6.26 Million
Q2 2020 Aug 11, 2020	BUY	$225.48 - $295.8 $5 Million - $6.55 Million	22,153 New	22,153 $6.44 Million

Others Institutions Holding VRTX

# of Institutions

1,784

Shares Held

236M

Call Options Held

1.95M

Put Options Held

1.14M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $109B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Uss Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Uss Investment Management LTD with notifications on news.

Account

Uss Investment Management LTD Vertex Pharmaceuticals Inc Transaction History